Robert Williamson
Founder
Robert F. Williamson, III is a seasoned biotech executive with over 25 years of experience building and leading innovative biotechnology companies. Currently, he holds various leadership positions in the industry, including Chairman and CEO of a stealth biotechnology company, Executive Chair of a stealth AI drug development company, and Compensation Committee Chair and Director of Perspective Therapeutics, a radiopharmaceutical company listed on the NYSE. Mr. Williamson has successfully led multiple companies through significant growth, maturation, clinical trials, partnerships, financing rounds, IPOs, and acquisitions. Notably, he served as an early Director of Pharmasset, Inc., where he helped guide the company's growth, IPO and eventual acquisition by Gilead for $11 billion. Prior to his career in biotech, Mr. Williamson was a partner with The Boston Consulting Group and a research assistant for the Federal Reserve Board of Governors in Washington, D.C. He holds a BA in economics from Pomona College and an MBA from Stanford University. Mr. Williamson also serves on the Coulter Oversight Board for University of Miami, FL.